NOD/LtSz-Rag1(null) mice: An immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells
Ld. Shultz et al., NOD/LtSz-Rag1(null) mice: An immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells, J IMMUNOL, 164(5), 2000, pp. 2496-2507
Development of a small animal model for the in vivo study of human immunity
and infectious disease remains an important goal, particularly for investi
gations of HIV vaccine development. NOD/Lt mice homozygous for the severe c
ombined immunodeficiency (Prkdc(scid)) mutation readily support engraftment
with high levels of human hematolymphoid cells. However, NOD/LtSz-scid mic
e are highly radiosensitive, have short life spans, and a small number deve
lop functional lymphocytes with age. To overcome these limitations, we have
backcrossed the null allele of the recombination-activating gene (Rag1) fo
r 10 generations onto the NOD/LtSz strain background, Mice deficient in RAG
1 activity are unable to initiate V(D)J recombination in Ig and TCR genes a
nd lack functional T and B lymphocytes, NOD/LtSz-Rag1(null) mice have an in
creased mean life span compared with NODntSz-scid mice due to a later onset
of lymphoma development, are radioresistant, and lack serum Ig throughout
life. NOD/LtSz-Rag1(null) mice were devoid of mature T or B cells. Cytotoxi
c assays demonstrated low NK cell activity. NOD/LtSz-Rag1(null) mice suppor
ted high levels of engraftment with human lymphoid cells and human hemopoie
tic stem cells. The engrafted human T cells were readily infected with HIV,
Finally, NOD/LtSz-Rag1(null) recipients of adoptively transferred spleen c
ells from diabetic NOD/Lt+/+ mice rapidly developed diabetes. These data de
monstrate the advantages of NOD/LtSz-Rag1(null) mice as a radiation and lym
phoma-resistant model for long-term analyses of engrafted human hematolymph
oid cells or diabetogenic NOD lymphoid cells.